Advanced search    

Search: authors:"S. Y. Kang"

5 papers found.
Use AND, OR, NOT, +word, -word, "long phrase", (parentheses) to fine-tune your search.

Correction to: Somatosensory and Motor Functions in Smartphone Systematic Users and Non-Users

of Foreign Studies , Yongin , Republic of Korea In the article metadata on SpringerLink, the email icon should appear after S. Y. Kang.

Multicentre phase II trial of bevacizumab combined with docetaxel–carboplatin for the neoadjuvant treatment of triple-negative breast cancer (KCSG BR-0905)

Background This phase II neoadjuvant trial evaluated bevacizumab–docetaxel and carboplatin in triple-negative breast cancer.

Age and HER2 expression status affect MRI accuracy in predicting residual tumor extent after neo-adjuvant systemic treatment

Background: Although recent studies suggest high accuracy of breast magnetic resonance imaging (MRI) in predicting residual tumor extent after neo-adjuvant systemic treatment (NST), its use is still controversial. In this study, we aimed to identify predictive factors of MRI accuracy after NST to determine a subgroup of patients in whom the use of MRI provides best additional ...

PLS. plenary session

Background Axitinib is a potent and selective second-generation inhibitor of vascular endothelial growth factor receptors 1–3. In the phase III AXIS study in second-line metastatic renal cell carcinoma (mRCC), axitinib demonstrated significant improvement in progression-free survival (PFS) compared with sorafenib (median PFS, 6.7 versus 4.7 months; hazard ratio [HR] 0.665; ...

OS1. gastric cancer

Background In advanced gastric cancer (AGC), several prognostic factors for survival time in first-line chemotherapy (1st-CTX) have been reported. However, there are few reports about the relationship between the effects of 1st-CTX and survival time from the start of 2nd-CTX (2nd-MST).